The healthcare sector, once a bustling hive of mergers and acquisitions (M&A) driven by private equity (PE) investment, is experiencing a marked deceleration. This slowdown is largely attributable to growing antitrust scrutiny from federal and state regulators, creating an environment of
The recent legislative decision by the Chilean Congress marks a significant shift for the country's private healthcare system, specifically targeting the private insurers known as Isapres. The bill, designed to support the struggling sector, includes a mandate that these insurers must
Healthcare technology is advancing rapidly, offering innovative solutions that can revolutionize patient care and streamline operations. However, one critical factor stands at the forefront of successfully integrating these technologies: trust. Trust in vendors, the technology itself, and the data
Cell and gene therapy hold tremendous promise for treating a wide array of diseases, including many that were previously considered untreatable. However, the high production costs associated with these advanced treatments pose a significant barrier to their widespread adoption. Automation emerges
The fields of cell and gene therapy have seen remarkable advancements and transformative updates over the past few years. As biotechnology companies strive to innovate and deliver groundbreaking solutions, significant milestones have been achieved, fostering hope and optimism for addressing some of
In an era marked by rapid advancements in medical technology, ensuring the safety and efficacy of medical devices remains paramount. The Food and Drug Administration (FDA) has been working diligently on developing a postmarket surveillance system, driven by a 2012 federal law aimed at reducing the
